本文通过系统评价和荟萃分析，研究 PI-RADS 2.1 升级规则对前列腺移行带（TZ）病变中前列腺癌（PCa）检出率的影响。发现 “2 + 1” 和 “3 + 1” 病变的癌症风险符合评分系统，但假阳性率高，对活检决策意义重大。 研究背景 磁共振成像（MRI）在前列腺癌（PCa）的 ...

本研究针对PI-RADS v2.1标准中外周区PI-RADS 3病灶因DCE-MRI阳性升级为4分(3+1病灶)的临床争议，通过专家共识构建特征词典，结合多 ...

Disparities in receipt of molecular imaging in biochemical recurrent prostate cancer. This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers Symposium. This abstract does not include a ...

The goal of this investigation was to retrospectively compare the recently proposed Prostate Imaging Reporting and Data System (PI-RADS) scale with the older Likert scale, using multiparametric MRI in ...

Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer. Prostate cancer (PCa) in 696 hypogonadal men with and without long-term testosterone therapy (TTh): ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...